Calibra Medical, Inc.

Company Summary

Calibra Medical is the maker of the Finesse “insulin patch-pen” for type 1 and type 2 diabetes.

Transaction Overview

The Company is acquired by Johnson & Johnson (“JNJ”) in a $77 million all-cash transaction

‍

Significance of the Transaction

Positions JNJ for leadership in the global market for the treatment of type 1 and type 2 diabetes Calibra gains access to JNJ’s extensive development, manufacturing, quality, commercialization and distribution network Calibra investors, including Canaan, Three Arch, Frazier and Skyline – along with management – achieve liquidity event

Healthios Role

If you would like to learn more information about this transaction contact us below.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Mergers & Acquisitions

Calibra Medical, Inc.

Has been acquired by

The undersigned acted as exclusive financial advisor to Calibra